NCT00242619View on ClinicalTrials.gov

Insulin Resistance in Patients With Mood Disorder

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
DepressionBipolar DisorderInsulin Resistance
Interventions
DRUG

rosiglitazone

Rosiglitazone was administered at two different doses over the 12-week period.

Trial Locations (1)

94305

Stanford University School of Medicine, Stanford

All Listed Sponsors
lead

Stanford University

OTHER

NCT00242619 - Insulin Resistance in Patients With Mood Disorder | Biotech Hunter | Biotech Hunter